{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:12:55Z","timestamp":1770066775860,"version":"3.49.0"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.phrs.2020.104762","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T12:18:40Z","timestamp":1584965920000},"page":"104762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Anti-arrhythmic properties of non-antiarrhythmic medications"],"prefix":"10.1016","volume":"156","author":[{"given":"Emmanuel Ato","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Ceraso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhiraj","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Barrett-Jolley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"October 17","key":"10.1016\/j.phrs.2020.104762_bib0005","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1161\/CIRCULATIONAHA.118.035455","article-title":"Modernized classification of cardiac antiarrhythmic drugs","volume":"138","author":"Lei","year":"2018","journal-title":"Circulation"},{"issue":"August 3","key":"10.1016\/j.phrs.2020.104762_bib0010","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0002-8703(61)90598-1","article-title":"Ion movements underlying the cardiac action potential","volume":"vol. 61","author":"WEIDMANN","year":"1961","journal-title":"Am. Heart J."},{"issue":"December 6","key":"10.1016\/j.phrs.2020.104762_bib0015","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/01.RES.73.6.1061","article-title":"Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents","volume":"vol. 73","author":"Wang","year":"1993","journal-title":"Circ. Res."},{"issue":"no. 2","key":"10.1016\/j.phrs.2020.104762_bib0020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ccep.2016.01.004","article-title":"Cardiac Delayed Rectifier Potassium Channels in Health and Disease","volume":"vol. 8","author":"Chen","year":"2016","journal-title":"Card. Electrophysiol. Clin."},{"issue":"February 3","key":"10.1016\/j.phrs.2020.104762_bib0025","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/CIRCRESAHA.109.208041","article-title":"The role of the funny current in pacemaker activity","volume":"vol. 106","author":"DiFrancesco","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2020.104762_bib0030","unstructured":"K. D. Singh and S. S. Karnik, Angiotensin Receptors: Structure, Function, Signaling and Clinical Applications."},{"issue":"September 3","key":"10.1016\/j.phrs.2020.104762_bib0035","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2796.2008.01981.x","article-title":"Renin-angiotensin system revisited","volume":"264","author":"Fyhrquist","year":"2008","journal-title":"J. Intern. Med."},{"issue":"no. 1","key":"10.1016\/j.phrs.2020.104762_bib0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/sj.bjp.0706445","article-title":"Angiotensin II and angiotensin II receptor blocker modulate the arrhythmogenic activity of pulmonary veins","volume":"vol. 147","author":"Chen","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"June 23","key":"10.1016\/j.phrs.2020.104762_bib0045","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1161\/01.CIR.101.23.2678","article-title":"Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans","volume":"vol. 101","author":"Goette","year":"2000","journal-title":"Circulation"},{"issue":"November 10","key":"10.1016\/j.phrs.2020.104762_bib0050","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1161\/01.RES.83.10.1035","article-title":"Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression","volume":"vol. 83","author":"Tsutsumi","year":"1998","journal-title":"Circ. Res."},{"issue":"December 24","key":"10.1016\/j.phrs.2020.104762_bib0055","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/01.CIR.98.24.2765","article-title":"Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo","volume":"vol. 98","author":"McEwan","year":"1998","journal-title":"Circulation"},{"issue":"no. 1","key":"10.1016\/j.phrs.2020.104762_bib0060","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.hrthm.2018.07.036","article-title":"Chronic in vivo angiotensin II administration differentially modulates the slow delayed rectifier channels in atrial and ventricular myocytes","volume":"vol. 16","author":"Zankov","year":"2019","journal-title":"Hear. Rhythm"},{"issue":"May. 10","key":"10.1016\/j.phrs.2020.104762_bib0065","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/01.RES.86.10.1062","article-title":"Effects of the renin-angiotensin system on the current I(to) in epicardial and endocardial ventricular myocytes from the canine heart","volume":"vol. 86","author":"Yu","year":"2000","journal-title":"Circ. Res."},{"issue":"February. 2","key":"10.1016\/j.phrs.2020.104762_bib0070","doi-asserted-by":"crossref","first-page":"H602","DOI":"10.1152\/ajpheart.00673.2003","article-title":"Phenotypic differences in transient outward K+ current of human and canine ventricular myocytes: insights into molecular composition of ventricular Ito","volume":"vol. 286","author":"Akar","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"November. 46","key":"10.1016\/j.phrs.2020.104762_bib0075","doi-asserted-by":"crossref","first-page":"48231","DOI":"10.1074\/jbc.M405789200","article-title":"Angiotensin receptor type 1 forms a complex with the transient outward potassium channel Kv4.3 and regulates its gating properties and intracellular localization","volume":"279","author":"Doronin","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"October.10","key":"10.1016\/j.phrs.2020.104762_bib0080","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/pace.12427","article-title":"Angiotensin-(1-7) prevent atrial tachycardia induced sodium channel remodeling","volume":"vol. 37","author":"Wang","year":"2014","journal-title":"Pacing Clin. Electrophysiol."},{"issue":"December 6","key":"10.1016\/j.phrs.2020.104762_bib0085","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/01.RES.81.6.1045","article-title":"Tachycardia-induced changes in Na+ current in a chronic dog model of atrial fibrillation","volume":"vol. 81","author":"Gaspo","year":"1997","journal-title":"Circ. Res."},{"issue":"August 8","key":"10.1016\/j.phrs.2020.104762_bib0090","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jacc.2015.06.1313","article-title":"Cardiac Fibrosis in Patients With Atrial Fibrillation","volume":"vol. 66","author":"Dzeshka","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"February 4","key":"10.1016\/j.phrs.2020.104762_bib0095","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"issue":"December 11","key":"10.1016\/j.phrs.2020.104762_bib0100","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1161\/01.CIR.94.11.2968","article-title":"Electrical remodeling in atrial fibrillation. Time course and mechanisms","volume":"vol. 94","author":"Goette","year":"1996","journal-title":"Circulation"},{"issue":"June. 12","key":"10.1016\/j.phrs.2020.104762_bib0105","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0735-1097(03)00464-9","article-title":"Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation","volume":"vol. 41","author":"Kumagai","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"October 4","key":"10.1016\/j.phrs.2020.104762_bib0110","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/01.RES.81.4.512","article-title":"Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation","volume":"vol. 81","author":"Yue","year":"1997","journal-title":"Circ. Res."},{"issue":"December 11","key":"10.1016\/j.phrs.2020.104762_bib0115","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1161\/01.CIR.96.11.4027","article-title":"Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model","volume":"vol. 96","author":"Gaspo","year":"1997","journal-title":"Circulation"},{"issue":"October 7","key":"10.1016\/j.phrs.2020.104762_bib0120","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1161\/01.CIR.94.7.1600","article-title":"Effect of atrial fibrillation on atrial refractoriness in humans","volume":"vol. 94","author":"Daoud","year":"1996","journal-title":"Circulation"},{"issue":"January 1","key":"10.1016\/j.phrs.2020.104762_bib0125","article-title":"Irbesartan prevents sodium channel remodeling in a canine model of atrial fibrillation","volume":"19","author":"Wang","year":"2018","journal-title":"J. Renin. Syst."},{"issue":"December 12","key":"10.1016\/j.phrs.2020.104762_bib0130","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s00380-016-0853-7","article-title":"Effect of irbesartan on development of atrial fibrosis and atrial fibrillation in a canine atrial tachycardia model with left ventricular dysfunction, association with p53","volume":"vol. 31","author":"Kataoka","year":"2016","journal-title":"Heart Vessels"},{"issue":"December 4","key":"10.1016\/j.phrs.2020.104762_bib0135","first-page":"341","article-title":"Irbesartan-mediated AT1 receptor blockade attenuates hyposmotic-induced enhancement of I Ks current and prevents shortening of action potential duration in atrial myocytes","volume":"15","author":"Wu","year":"2014","journal-title":"J. Renin. Syst."},{"issue":"June 22","key":"10.1016\/j.phrs.2020.104762_bib0140","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1161\/01.CIR.101.22.2612","article-title":"Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation","volume":"vol. 101","author":"Nakashima","year":"2000","journal-title":"Circulation"},{"issue":"July 3","key":"10.1016\/j.phrs.2020.104762_bib0145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/01.CIR.0000022665.18619.83","article-title":"Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study","volume":"vol. 106","author":"Madrid","year":"2002","journal-title":"Circulation"},{"issue":"September 3","key":"10.1016\/j.phrs.2020.104762_bib0150","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1023\/B:CEPR.0000012391.95928.d2","article-title":"Angiotensin receptor blocker as adjunctive therapy for rhythm control in atrial fibrillation: results of the irbesartan-amiodarone trial","volume":"vol. 7","author":"Madrid","year":"2003","journal-title":"Card. Electrophysiol. Rev."},{"issue":"December 5","key":"10.1016\/j.phrs.2020.104762_bib0155","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0092-8674(93)90541-W","article-title":"Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro","volume":"vol. 75","author":"Sadoshima","year":"1993","journal-title":"Cell"},{"issue":"November 5","key":"10.1016\/j.phrs.2020.104762_bib0160","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/01.HYP.36.5.845","article-title":"Angiotensin II type 2 receptors stimulate collagen synthesis in cultured vascular smooth muscle cells","volume":"vol. 36","author":"Mifune","year":"2000","journal-title":"Hypertens. (Dallas, Tex. 1979)"},{"issue":"July 1","key":"10.1016\/j.phrs.2020.104762_bib0165","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.100.1.87","article-title":"Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort","volume":"vol. 100","author":"Li","year":"1999","journal-title":"Circulation"},{"issue":"January 1","key":"10.1016\/j.phrs.2020.104762_bib0170","doi-asserted-by":"crossref","first-page":"C372","DOI":"10.1152\/ajpcell.00186.2007","article-title":"NF-kappaB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II","volume":"294","author":"Shang","year":"2008","journal-title":"Am. J. Physiol., Cell Physiol."},{"issue":"February 4","key":"10.1016\/j.phrs.2020.104762_bib0175","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/01.CIR.97.4.315","article-title":"Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias","volume":"vol. 97","author":"Harada","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2020.104762_bib0180","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.100.4.376","article-title":"Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction","author":"Pedersen","year":"1999","journal-title":"Circulation"},{"issue":"November 5","key":"10.1016\/j.phrs.2020.104762_bib0185","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/heart.86.5.527","article-title":"Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data","volume":"vol. 86","author":"Pizzetti","year":"2001","journal-title":"Heart"},{"issue":"September 8","key":"10.1016\/j.phrs.2020.104762_bib0190","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0002-9149(85)91186-5","article-title":"Effect of enalapril on ventricular arrhythmias in congestive heart failure","volume":"vol. 56","author":"Webster","year":"1985","journal-title":"Am. J. Cardiol."},{"issue":"June 23","key":"10.1016\/j.phrs.2020.104762_bib0195","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1161\/01.CIR.0000072793.81076.D4","article-title":"Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies of left Ventricular Dysfunction (SOLVD) trials","volume":"107","author":"Vermes","year":"2003","journal-title":"Circulation"},{"issue":"March 3","key":"10.1016\/j.phrs.2020.104762_bib0200","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ahj.2004.09.033","article-title":"Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)","volume":"vol. 149","author":"Maggioni","year":"2005","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/j.phrs.2020.104762_bib0205","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ahj.2005.06.036","article-title":"Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"152","author":"Ducharme","year":"2006","journal-title":"Am. Heart J."},{"issue":"September 3","key":"10.1016\/j.phrs.2020.104762_bib0210","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ahj.2007.04.062","article-title":"Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study","volume":"vol. 154","author":"Salehian","year":"2007","journal-title":"Am. Heart J."},{"issue":"March 3","key":"10.1016\/j.phrs.2020.104762_bib0215","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/HJH.0b013e3282f35c67","article-title":"Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial","volume":"vol. 26","author":"Schmieder","year":"2008","journal-title":"J. Hypertens."},{"issue":"April 16","key":"10.1016\/j.phrs.2020.104762_bib0220","first-page":"1606","article-title":"Valsartan for prevention of recurrent atrial fibrillation","volume":"vol. 360","author":"Disertori","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"April 15","key":"10.1016\/j.phrs.2020.104762_bib0225","first-page":"1547","article-title":"Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events","volume":"vol. 358","author":"The ONTARGET Investigators","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"March 10","key":"10.1016\/j.phrs.2020.104762_bib0230","first-page":"928","article-title":"Irbesartan in patients with atrial fibrillation","volume":"vol. 364","author":"Yusuf","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"April 4","key":"10.1016\/j.phrs.2020.104762_bib0235","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/europace\/euq439","article-title":"Randomized trial of angiotensin II-receptor blocker vs. Dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study)","volume":"13","author":"Yamashita","year":"2011","journal-title":"Europace"},{"issue":"21","key":"10.1016\/j.phrs.2020.104762_bib0240","first-page":"2299","article-title":"Prevention of atrial fibrillation by renin-angiotensin system inhibition","volume":"55","author":"Schneider","year":"2010","journal-title":"JAC"},{"issue":"5","key":"10.1016\/j.phrs.2020.104762_bib0245","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2004.10.068","article-title":"Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention for End point reduction in hypertension (LIFE) study","volume":"45","author":"Wachtell","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2020.104762_bib0250","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijcard.2006.08.086","article-title":"Candesartan in the prevention of relapsing atrial fibrillation \u22c6","volume":"vol. 120","author":"Tveit","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2020.104762_bib0255","doi-asserted-by":"crossref","unstructured":"M. Palardy, A. Ducharme, S. Nattel, J.-C. Tardif, M. White, N. Racine, K. Tetreault, F. Dabouz, M. Talajic, and D. Roy, Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF), Can. J. Cardiol., vol. 24, September 9, pp. 709\u2013713.","DOI":"10.1016\/S0828-282X(08)70670-6"},{"key":"10.1016\/j.phrs.2020.104762_bib0260","doi-asserted-by":"crossref","unstructured":"C. R. Sirtori, The pharmacology of statins, Pharmacol. Res., vol. 88, pp. 3\u201311, October 4.","DOI":"10.1016\/j.phrs.2014.03.002"},{"issue":"no. 5","key":"10.1016\/j.phrs.2020.104762_bib0265","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4103\/2230-8210.163106","article-title":"Pleiotropic effects of statins","volume":"vol. 19","author":"Kavalipati","year":"2015","journal-title":"Indian J. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2020.104762_bib0270","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-1-4939-6996-8_18","article-title":"Isoprenylation of monomeric GTPases in human trabecular meshwork cells","volume":"1609","author":"Stubbs","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.phrs.2020.104762_bib0275","doi-asserted-by":"crossref","unstructured":"T. M. De Silva, D. A. Kinzenbaw, M. L. Modrick, L. D. Reinhardt, and F. M. Faraci, Heterogeneous Impact of ROCK2 on Carotid and Cerebrovascular Function, Hypertens. (Dallas, Tex. 1979), vol. 68, September 3, 809\u2013817.","DOI":"10.1161\/HYPERTENSIONAHA.116.07430"},{"issue":"March 8","key":"10.1016\/j.phrs.2020.104762_bib0280","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1089\/ars.2013.5524","article-title":"Rho\/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis","volume":"vol. 20","author":"Sawada","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"July 1","key":"10.1016\/j.phrs.2020.104762_bib0285","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/HYPERTENSIONAHA.117.10799","article-title":"Endothelial PPARgamma (Peroxisome proliferator-activated receptor-gamma) is essential for preventing endothelial dysfunction with aging","volume":"72","author":"De Silva","year":"2018","journal-title":"Hypertens. (Dallas, Tex. 1979)"},{"issue":"July 1","key":"10.1016\/j.phrs.2020.104762_bib0290","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1172\/JCI9639","article-title":"Neuroprotection mediated by changes in the endothelial actin cytoskeleton","volume":"vol. 106","author":"Laufs","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"July 1","key":"10.1016\/j.phrs.2020.104762_bib0295","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/01.CIR.0000020682.73694.AB","article-title":"Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase","volume":"vol. 106","author":"Takemoto","year":"2002","journal-title":"Circulation"},{"issue":"May 20","key":"10.1016\/j.phrs.2020.104762_bib0300","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1001\/jama.279.20.1643","article-title":"Antiatherothrombotic properties of statins: implications for cardiovascular event reduction","volume":"vol. 279","author":"Rosenson","year":"1998","journal-title":"JAMA"},{"issue":"Suppl December","key":"10.1016\/j.phrs.2020.104762_bib0305","first-page":"22","article-title":"Halting the progression of atherosclerosis with intensive lipid lowering: results from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial","volume":"118","author":"Nissen","year":"2005","journal-title":"Alami J."},{"issue":"May 9","key":"10.1016\/j.phrs.2020.104762_bib0310","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.RES.84.9.1043","article-title":"Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation","volume":"vol. 84","author":"Li","year":"1999","journal-title":"Circ. Res."},{"issue":"October 16","key":"10.1016\/j.phrs.2020.104762_bib0315","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1161\/01.CIR.102.16.1970","article-title":"Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB","volume":"vol. 102","author":"Li","year":"2000","journal-title":"Circulation"},{"issue":"no. 3","key":"10.1016\/j.phrs.2020.104762_bib0320","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0005-2760(93)90145-Y","article-title":"Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages","volume":"vol. 1165","author":"Giroux","year":"1993","journal-title":"Biochim. Biophys. Acta - Lipids Lipid Metab."},{"issue":"December 12","key":"10.1016\/j.phrs.2020.104762_bib0325","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"vol. 6","author":"Kwak","year":"2000","journal-title":"Nat. Med."},{"issue":"July 31","key":"10.1016\/j.phrs.2020.104762_bib0330","doi-asserted-by":"crossref","first-page":"21926","DOI":"10.1074\/jbc.274.31.21926","article-title":"3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1)","volume":"vol. 274","author":"Laufs","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"December 50","key":"10.1016\/j.phrs.2020.104762_bib0335","doi-asserted-by":"crossref","first-page":"31725","DOI":"10.1074\/jbc.272.50.31725","article-title":"Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase","volume":"vol. 272","author":"Laufs","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"September 9","key":"10.1016\/j.phrs.2020.104762_bib0340","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/79510","article-title":"The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals","volume":"vol. 6","author":"Kureishi","year":"2000","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.phrs.2020.104762_bib0345","doi-asserted-by":"crossref","first-page":"e0157171","DOI":"10.1371\/journal.pone.0157171","article-title":"The effects and mechanism of atorvastatin on pulmonary hypertension due to left heart disease","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"issue":"November 10","key":"10.1016\/j.phrs.2020.104762_bib0350","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1164\/rccm.200203-268OC","article-title":"Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats","volume":"vol. 166","author":"Nishimura","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"June 5","key":"10.1016\/j.phrs.2020.104762_bib0355","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/01902140902736819","article-title":"Simvastatin restores down-regulated GATA-6 expression in pulmonary hypertensive rats","volume":"vol. 35","author":"Liu","year":"2009","journal-title":"Exp. Lung Res."},{"issue":"July 7","key":"10.1016\/j.phrs.2020.104762_bib0360","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1097\/HJH.0000000000000184","article-title":"Atorvastatin ameliorates cardiac fibrosis and improves left ventricular diastolic function in hypertensive diastolic heart failure model rats","volume":"vol. 32","author":"Akahori","year":"2014","journal-title":"J. Hypertens."},{"issue":"May 5","key":"10.1016\/j.phrs.2020.104762_bib0365","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.phrs.2008.04.001","article-title":"Short- and long-term effect of simvastatin therapy on the heterogeneity of cardiac repolarization in diabetic patients","volume":"vol. 57","author":"Tekin","year":"2008","journal-title":"Pharmacol. Res."},{"issue":"August 3","key":"10.1016\/j.phrs.2020.104762_bib0370","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0167-5273(98)00120-X","article-title":"Clinical significance of QT dispersion after exercise in patients with previous myocardial infarction","volume":"vol. 65","author":"Yu","year":"1998","journal-title":"Int. J. Cardiol."},{"issue":"December 9","key":"10.1016\/j.phrs.2020.104762_bib0375","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cardfail.2005.06.439","article-title":"Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure","volume":"vol. 11","author":"Vrtovec","year":"2005","journal-title":"J. Card. Fail."},{"issue":"January 1","key":"10.1016\/j.phrs.2020.104762_bib0380","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/hrt.65.1.14","article-title":"Prognostic value of reduced heart rate variability after myocardial infarction: clinical evaluation of a new analysis method","volume":"vol. 65","author":"Cripps","year":"1991","journal-title":"Br. Heart J."},{"issue":"no. 5","key":"10.1016\/j.phrs.2020.104762_bib0385","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/0002-9149(91)90774-F","article-title":"Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction","volume":"vol. 68","author":"Odemuyiwa","year":"1991","journal-title":"Am. J. Cardiol."},{"issue":"October 15\u201316","key":"10.1016\/j.phrs.2020.104762_bib0390","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.lfs.2010.09.010","article-title":"Atorvastatin treatment affects atrial ion currents and their tachycardia-induced remodeling in rabbits","volume":"vol. 87","author":"Laszlo","year":"2010","journal-title":"Life Sci."},{"issue":"July 1","key":"10.1016\/j.phrs.2020.104762_bib0395","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cardiores.2007.02.029","article-title":"Do statins have an antiarrhythmic activity?","volume":"vol. 75","author":"Kostapanos","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"September 1","key":"10.1016\/j.phrs.2020.104762_bib0400","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40360-016-0086-5","article-title":"Current statins show calcium channel blocking activity through voltage gated channels","volume":"vol. 17","author":"Ali","year":"2016","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"May 5","key":"10.1016\/j.phrs.2020.104762_bib0405","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.jcbfm.9600406","article-title":"Rho-kinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanisms","volume":"vol. 27","author":"Shin","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"June 6736","key":"10.1016\/j.phrs.2020.104762_bib0410","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/21224","article-title":"Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation","volume":"vol. 399","author":"Dimmeler","year":"1999","journal-title":"Nature"},{"issue":"July 15","key":"10.1016\/j.phrs.2020.104762_bib0415","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0960-9822(99)80371-6","article-title":"The Akt kinase signals directly to endothelial nitric oxide synthase","volume":"vol. 9","author":"Michell","year":"1999","journal-title":"Curr. Biol."},{"issue":"August 3","key":"10.1016\/j.phrs.2020.104762_bib0420","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1172\/JCI200113152","article-title":"HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase\/Akt pathway","volume":"vol. 108","author":"Dimmeler","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"August 4","key":"10.1016\/j.phrs.2020.104762_bib0425","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1254\/jphs.FP0060102","article-title":"The effects of HMG-CoA reductase inhibitor on vascular progenitor cells","volume":"vol. 101","author":"Kusuyama","year":"2006","journal-title":"J. Pharmacol. Sci."},{"issue":"June 12","key":"10.1016\/j.phrs.2020.104762_bib0430","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1172\/JCI1500","article-title":"Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells","volume":"vol. 101","author":"Hernandez-Perera","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"Suppl April","key":"10.1016\/j.phrs.2020.104762_bib0435","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/S0021-9150(97)00319-5","article-title":"Direct vascular effects of HMG-CoA reductase inhibitors","volume":"vol. 137","author":"Bellosta","year":"1998","journal-title":"Atherosclerosis"},{"issue":"July 3","key":"10.1016\/j.phrs.2020.104762_bib0440","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1254\/jjp.86.289","article-title":"Effects of fluvastatin and its major metabolites on low-density lipoprotein oxidation and cholesterol esterification in macrophages","volume":"vol. 86","author":"Tanaka","year":"2001","journal-title":"Jpn. J. Pharmacol."},{"issue":"November 2","key":"10.1016\/j.phrs.2020.104762_bib0445","first-page":"311","article-title":"Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability","volume":"vol. 86","author":"Massaro","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2020.104762_bib0450","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.vph.2016.01.007","article-title":"Cholesterol-independent effects of atorvastatin prevent cardiovascular morbidity and mortality in a mouse model of atherosclerotic plaque rupture","volume":"vol. 80","author":"Roth","year":"2016","journal-title":"Vascul. Pharmacol."},{"issue":"March 3","key":"10.1016\/j.phrs.2020.104762_bib0455","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0026-895X(24)12257-2","article-title":"Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase","volume":"vol. 59","author":"Wassmann","year":"2001","journal-title":"Mol. Pharmacol."},{"issue":"February 2","key":"10.1016\/j.phrs.2020.104762_bib0460","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/hq0202.104081","article-title":"Cellular antioxidant effects of atorvastatin in vitro and in vivo","volume":"vol. 22","author":"Wassmann","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2020.104762_bib0465","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-016-1252-4","article-title":"Pleiotropic effects of statins: new therapeutic targets in drug design","author":"Bedi","year":"2016","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"November 11","key":"10.1016\/j.phrs.2020.104762_bib0470","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1002\/art.22169","article-title":"RhoA-mediated, tumor necrosis factor alpha-induced activation of NF-kappaB in rheumatoid synoviocytes: inhibitory effect of simvastatin","volume":"vol. 54","author":"Xu","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"August 3","key":"10.1016\/j.phrs.2020.104762_bib0475","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/01.RES.0000177090.07296.ac","article-title":"Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy","volume":"vol. 97","author":"Senthil","year":"2005","journal-title":"Circ. Res."},{"issue":"January 1","key":"10.1016\/j.phrs.2020.104762_bib0480","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCRESAHA.107.163493","article-title":"Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency","volume":"vol. 102","author":"Yagi","year":"2008","journal-title":"Circ. Res."},{"issue":"August 8","key":"10.1016\/j.phrs.2020.104762_bib0485","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jacc.2012.03.041","article-title":"Reduction in Life-Threatening Ventricular Tachyarrhythmias in Statin-Treated Patients With Nonischemic Cardiomyopathy Enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)","volume":"vol. 60","author":"Buber","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"February 4","key":"10.1016\/j.phrs.2020.104762_bib0490","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jacc.2005.09.053","article-title":"Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II","volume":"vol. 47","author":"Vyas","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"no. 1","key":"10.1016\/j.phrs.2020.104762_bib0495","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0735-1097(03)00498-4","article-title":"Are Lipid-Lowering Drugs Also Antiarrhythmic Drugs? An Analysis of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial","volume":"vol. 42","author":"Mitchell","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"December 12","key":"10.1016\/j.phrs.2020.104762_bib0500","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.amjcard.2009.07.045","article-title":"Impact of prior statin therapy on arrhythmic events in patients with acute coronary syndromes (from the Global Registry of Acute Coronary Events [GRACE])","volume":"vol. 104","author":"Vedre","year":"2009","journal-title":"Am. J. Cardiol."},{"issue":"no. 1","key":"10.1016\/j.phrs.2020.104762_bib0505","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/heartasia-2012-010225","article-title":"Association of statin therapy with ventricular arrhythmias among patients with acute coronary syndrome","volume":"vol. 5","author":"Apiyasawat","year":"2013","journal-title":"Heart Asia"},{"issue":"November 10","key":"10.1016\/j.phrs.2020.104762_bib0510","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1161\/01.CIR.96.10.3542","article-title":"Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia","volume":"vol. 96","author":"Bruins","year":"1997","journal-title":"Circulation"},{"issue":"February 2","key":"10.1016\/j.phrs.2020.104762_bib0515","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.amjmed.2012.06.027","article-title":"CHADS2 score, statin therapy, and risks of atrial fibrillation","volume":"126","author":"Hung","year":"2013","journal-title":"Am. J. Med."},{"issue":"no. 10","key":"10.1016\/j.phrs.2020.104762_bib0520","doi-asserted-by":"crossref","first-page":"e0186972","DOI":"10.1371\/journal.pone.0186972","article-title":"Statins and new-onset atrial fibrillation in a cohort of patients with hypertension. Analysis of electronic health records, 2006-2015","volume":"vol. 12","author":"Alves-Cabratosa","year":"2017","journal-title":"PLoS One"},{"issue":"November 5","key":"10.1016\/j.phrs.2020.104762_bib0525","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1365-2125.2012.04258.x","article-title":"The role of statin therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials","volume":"vol. 74","author":"Fang","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"October 19","key":"10.1016\/j.phrs.2020.104762_bib0530","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1093\/eurheartj\/ehp357","article-title":"Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial","volume":"vol. 30","author":"Maggioni","year":"2009","journal-title":"Eur. Heart J."},{"issue":"September 12","key":"10.1016\/j.phrs.2020.104762_bib0535","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1161\/01.CIR.0000029743.68247.31","article-title":"Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction","volume":"vol. 106","author":"Plenge","year":"2002","journal-title":"Circulation"},{"issue":"no. 3","key":"10.1016\/j.phrs.2020.104762_bib0540","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000012782","article-title":"Replacing saturated fat with PUFA-rich (sunflower oil) or MUFA-rich (rapeseed, olive and high-oleic sunflower oil) fats resulted in comparable hypocholesterolemic effects in cholesterol-fed hamsters","volume":"vol. 43","author":"Trautwein","year":"1999","journal-title":"Ann. Nutr. Metab."},{"issue":"October 10","key":"10.1016\/j.phrs.2020.104762_bib0545","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1194\/jlr.M026179","article-title":"Dietary oxidized n-3 PUFA induce oxidative stress and inflammation: role of intestinal absorption of 4-HHE and reactivity in intestinal cells","volume":"vol. 53","author":"Awada","year":"2012","journal-title":"J. Lipid Res."},{"issue":"January 1","key":"10.1016\/j.phrs.2020.104762_bib0550","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1124\/pr.117.014092","article-title":"Anti-Inflammatory Effects of Omega-3 Fatty Acids in the Brain: Physiological Mechanisms and Relevance to Pharmacology","volume":"vol. 70","author":"Laye","year":"2018","journal-title":"Pharmacol. Rev."},{"issue":"19","key":"10.1016\/j.phrs.2020.104762_bib0555","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJM198505093121901","article-title":"The inverse relation between fish consumption and 20-year mortality from coronary heart disease","volume":"312","author":"Kromhout","year":"1985","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.phrs.2020.104762_bib0560","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2011.06.063","article-title":"Omega-3 fatty acids and cardiovascular disease: Effects on risk factors, molecular pathways, and clinical events","volume":"58","author":"Mozaffarian","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"no. 4","key":"10.1016\/j.phrs.2020.104762_bib0565","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/01.CIR.0000138154.00779.A5","article-title":"Fish intake and risk of incident atrial fibrillation","volume":"vol. 110","author":"Mozaffarian","year":"2004","journal-title":"Circulation"},{"issue":"no. 23","key":"10.1016\/j.phrs.2020.104762_bib0570","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1161\/CIRCULATIONAHA.109.852657","article-title":"Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men","volume":"vol. 120","author":"Virtanen","year":"2009","journal-title":"Circulation"},{"issue":"no. 6","key":"10.1016\/j.phrs.2020.104762_bib0575","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.amjcard.2009.11.039","article-title":"Dietary Fish Intake and Incident Atrial Fibrillation (from the Women\u2019s Health Initiative)","volume":"vol. 105","author":"Berry","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phrs.2020.104762_bib0580","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003177.pub4","article-title":"Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease","author":"Abdelhamid","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"November 3","key":"10.1016\/j.phrs.2020.104762_bib0585","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0006-291X(83)80254-X","article-title":"Thromboxane A3 (TXA3) is formed in human platelets after dietary eicosapentaenoic acid (C20:5 omega 3)","volume":"116","author":"Fischer","year":"1983","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"March 8166","key":"10.1016\/j.phrs.2020.104762_bib0590","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0140-6736(80)90995-2","article-title":"Platelet-membrane fatty acids, platelet aggregation, and thromboxane formation during a mackerel diet","volume":"vol. 1","author":"Siess","year":"1980","journal-title":"Lancet (London, England)"},{"issue":"March 3","key":"10.1016\/j.phrs.2020.104762_bib0595","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/jn\/127.3.383","article-title":"Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action","volume":"vol. 127","author":"Nair","year":"1997","journal-title":"J. Nutr."},{"issue":"January 1","key":"10.1016\/j.phrs.2020.104762_bib0600","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/ajcn\/51.1.53","article-title":"Reversal of the arrhythmogenic effects of long-term saturated fatty acid intake by dietary n-3 and n-6 polyunsaturated fatty acids","volume":"51","author":"McLennan","year":"1990","journal-title":"Am. J. Clin. Nutr."},{"issue":"April 15","key":"10.1016\/j.phrs.2020.104762_bib0605","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa012918","article-title":"Blood levels of long-chain n-3 fatty acids and the risk of sudden death","volume":"vol. 346","author":"Albert","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"August 7","key":"10.1016\/j.phrs.2020.104762_bib0610","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/hc3201.094151","article-title":"Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population","volume":"vol. 104","author":"Jouven","year":"2001","journal-title":"Circulation"},{"issue":"April. 8","key":"10.1016\/j.phrs.2020.104762_bib0615","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1073\/pnas.94.8.4182","article-title":"Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes","volume":"vol. 94","author":"Xiao","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"March 5","key":"10.1016\/j.phrs.2020.104762_bib0620","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1073\/pnas.95.5.2680","article-title":"Fatty acids suppress voltage-gated Na+ currents in HEK293t cells transfected with the alpha-subunit of the human cardiac Na+ channel","volume":"vol. 95","author":"Xiao","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7\u20138","key":"10.1016\/j.phrs.2020.104762_bib0625","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0955-2863(00)00094-2","article-title":"Effects of dietary n-3 fatty acids on contractility, Na+ and K+ currents in a rat cardiomyocyte model of arrhythmia","volume":"vol.11","author":"Leifert","year":"2000","journal-title":"J. Nutr. Biochem."},{"issue":"April 9","key":"10.1016\/j.phrs.2020.104762_bib0630","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1073\/pnas.92.9.3997","article-title":"Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes","volume":"vol. 92","author":"Kang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"December 3","key":"10.1016\/j.phrs.2020.104762_bib0635","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00232-001-0095-0","article-title":"The modulation of ionic currents in excitable tissues by n-3 polyunsaturated fatty acids","volume":"vol. 184","author":"Leaf","year":"2001","journal-title":"J. Membr. Biol."},{"issue":"November 2","key":"10.1016\/j.phrs.2020.104762_bib0640","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0008-6363(03)00545-5","article-title":"Effects of eicosapentaenoic acid on cardiac SR Ca(2+)-release and ryanodine receptor function","volume":"vol. 60","author":"Swan","year":"2003","journal-title":"Cardiovasc. Res."},{"issue":"December 6","key":"10.1016\/j.phrs.2020.104762_bib0645","first-page":"717","article-title":"Omega-3 fatty acids and atorvastatin suppress ventricular fibrillation inducibility in hypertriglyceridemic rat hearts: implication of intracellular coupling protein, connexin-43","volume":"vol. 61","author":"Bacova","year":"2010","journal-title":"J. Physiol. Pharmacol."},{"issue":"February 1","key":"10.1016\/j.phrs.2020.104762_bib0650","first-page":"83","article-title":"Acute anti-fibrillating and defibrillating potential of atorvastatin, melatonin, eicosapentaenoic acid and docosahexaenoic acid demonstrated in isolated heart model","volume":"vol. 66","author":"Benova","year":"2015","journal-title":"J. Physiol. Pharmacol."},{"issue":"Suppl 5 October","key":"10.1016\/j.phrs.2020.104762_bib0655","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0022-2828(87)80610-7","article-title":"Eicosanoids and susceptibility to ventricular arrhythmias during myocardial ischaemia and reperfusion","volume":"vol.19","author":"Parratt","year":"1987","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"February Pt 2","key":"10.1016\/j.phrs.2020.104762_bib0660","first-page":"H379","article-title":"Differential effects of dietary fish oil on myocardial prostaglandin I2 and thromboxane A2 production","volume":"vol. 260","author":"Abeywardena","year":"1991","journal-title":"Am. J. Physiol."},{"issue":"March 5","key":"10.1016\/j.phrs.2020.104762_bib0665","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1073\/pnas.89.5.1760","article-title":"Modulation of dihydropyridine-sensitive calcium channels in heart cells by fish oil fatty acids","volume":"vol. 89","author":"Hallaq","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"September 19","key":"10.1016\/j.phrs.2020.104762_bib0670","doi-asserted-by":"crossref","first-page":"8832","DOI":"10.1073\/pnas.91.19.8832","article-title":"Omega 3 polyunsaturated fatty acid modulates dihydropyridine effects on L-type Ca2+ channels, cytosolic Ca2+, and contraction in adult rat cardiac myocytes","volume":"vol. 91","author":"Pepe","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"June 12","key":"10.1016\/j.phrs.2020.104762_bib0675","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0002-9149(97)00220-8","article-title":"Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction","volume":"vol. 79","author":"Christensen","year":"1997","journal-title":"Am. J. Cardiol."},{"issue":"no. 1","key":"10.1016\/j.phrs.2020.104762_bib0680","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.atherosclerosis.2015.07.035","article-title":"Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis","volume":"vol. 242","author":"Borow","year":"2015","journal-title":"Atherosclerosis"},{"issue":"no. 1","key":"10.1016\/j.phrs.2020.104762_bib0685","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.atherosclerosis.2010.05.022","article-title":"Eicosapentaenoic acid (EPA) from highly concentrated n\u22123 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability","volume":"vol. 212","author":"Cawood","year":"2010","journal-title":"Atherosclerosis"},{"issue":"no. 1","key":"10.1016\/j.phrs.2020.104762_bib0690","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.atherosclerosis.2014.02.025","article-title":"Stabilizing effect of combined eicosapentaenoic acid and statin therapy on coronary thin-cap fibroatheroma","volume":"vol. 234","author":"Nishio","year":"2014","journal-title":"Atherosclerosis"},{"issue":"February 6","key":"10.1016\/j.phrs.2020.104762_bib0695","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/CIRCULATIONAHA.110.971853","article-title":"Omega-3 fatty acids prevent pressure overload-induced cardiac fibrosis through activation of cyclic GMP\/protein kinase G signaling in cardiac fibroblasts","volume":"vol. 123","author":"Chen","year":"2011","journal-title":"Circulation"},{"issue":"April 4","key":"10.1016\/j.phrs.2020.104762_bib0700","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.hrthm.2009.12.016","article-title":"n-3 Polyunsaturated fatty acids alter expression of fibrotic and hypertrophic genes in a dog model of atrial cardiomyopathy","volume":"vol. 7","author":"Ramadeen","year":"2010","journal-title":"Hear. Rhythm"},{"issue":"November 11","key":"10.1016\/j.phrs.2020.104762_bib0705","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1139\/y85-232","article-title":"Influence of dietary lipids on arrhythmias and infarction after coronary artery ligation in rats","volume":"vol. 63","author":"McLennan","year":"1985","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"November 18","key":"10.1016\/j.phrs.2020.104762_bib0710","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1161\/CIRCULATIONAHA.105.549527","article-title":"Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake","volume":"vol. 112","author":"Leaf","year":"2005","journal-title":"Circulation"},{"issue":"June 23","key":"10.1016\/j.phrs.2020.104762_bib0715","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1001\/jama.293.23.2884","article-title":"Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial","volume":"vol. 293","author":"Raitt","year":"2005","journal-title":"JAMA"},{"issue":"8666","key":"10.1016\/j.phrs.2020.104762_bib0720","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(89)90828-3","article-title":"Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART)","volume":"334","author":"Burr","year":"1989","journal-title":"Lancet"},{"issue":"no. 3","key":"10.1016\/j.phrs.2020.104762_bib0725","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCEP.111.966739","article-title":"Dietary Omega-3 Fatty Acids and Susceptibility to Ventricular Fibrillation","volume":"vol. 5","author":"Billman","year":"2012","journal-title":"Circ. Arrhythmia Electrophysiol."},{"issue":"no. 23","key":"10.1016\/j.phrs.2020.104762_bib0730","first-page":"2781","article-title":"Fish oil for the prevention of post-operative atrial fibrillation - the omega-3 fatty acids for prevention of post-operative atrial fibrillation (OPERA) trial","volume":"vol. 126","author":"M. R","year":"2012","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.phrs.2020.104762_bib0735","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1001\/jama.2010.1735","article-title":"Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: A randomized controlled trial","volume":"304","author":"Kowey","year":"2010","journal-title":"JAMA J. Am. Med. Assoc."},{"issue":"3","key":"10.1016\/j.phrs.2020.104762_bib0740","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.111.000547","article-title":"A randomized, placebo\u2010controlled trial of omega\u20103 fatty acids for inhibition of supraventricular arrhythmias after cardiac surgery: the FISH trial","volume":"1","author":"Sandesara","year":"2012","journal-title":"J. Am. Heart Assoc."},{"issue":"December","key":"10.1016\/j.phrs.2020.104762_bib0745","article-title":"Omega-3 polyunsaturated fatty acids and cardiac rhythm: an introduction","volume":"3","author":"Billman","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2020.104762_bib0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/neuro.11.001.2009","article-title":"NEURON and Python","volume":"vol. 3","author":"Hines","year":"2009","journal-title":"Front. Neuroinform."},{"issue":"January 1133","key":"10.1016\/j.phrs.2020.104762_bib0755","first-page":"353","article-title":"A model of cardiac electrical activity incorporating ionic pumps and concentration changes","volume":"307","author":"DiFrancesco","year":"1985","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"September 3","key":"10.1016\/j.phrs.2020.104762_bib0760","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1124\/mol.119.116400","article-title":"Temperature Dependence of the Biophysical Mechanisms Underlying the Inhibition and Enhancement Effect of Amiodarone on hERG Channels","volume":"vol. 96","author":"Lo","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2020.104762_bib0765","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vascn.2017.04.002","article-title":"Cardiac voltage-gated ion channels in safety pharmacology: review of the landscape leading to the CiPA initiative","volume":"87","author":"Huang","year":"2017","journal-title":"J. Pharmacol. Toxicol. Methods"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819320055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819320055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:10:30Z","timestamp":1760911830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661819320055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":153,"alternative-id":["S1043661819320055"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104762","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-arrhythmic properties of non-antiarrhythmic medications","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104762"}}